DERMFREE ORIGINAL NASAL

Manufacturer
Jiangxi Yudexi Pharmaceutical Co., LTD
Effective date
2025-05-02
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:39:21

Label at a glance#

ProductDERMFREE ORIGINAL NASAL
Active ingredientNAPHAZOLINE HCL
Label structure13 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient
Naphazoline HCL0.05%

OTC - PURPOSE SECTION

Purpose
Nasal Decongestant

INDICATIONS & USAGE SECTION

Use
temporarily relieves ·Nasal congestion due to a cold, hay fever, or other upper respiratory allergies ·Sinus congestion and pressure

WARNINGS SECTION

Warnings
1.Do not use if you are allergic to the ingredients. 2.Ask a doctor before use if you have
Heart disease、High blood pressure、Thyroid disease、Diabetes、Trouble urinating due to enlarged prostate gland 3.When using this product
·Do not exceed recommended dosage
·After continuous use for 3 days, please stop using for 1 day, please use as instructed.Do not use without nasal congestion.Frequent or prolonged use may cause nasalcongestion to recur or worsen.
·Temporary discomfort such as burning, stinging, sneezing, or increased nasal discharge may occur.
·Use of this container by more than one person may spread infection.

OTC - DO NOT USE SECTION

Do not use
children under 6 years

OTC - WHEN USING SECTION

When Using
After continuous use for 3 days, please stop using for 1 day, please use as instructed.Do not use without nasal congestion.Frequent or prolonged use may cause nasalcongestion to recur or worsen..
·Temporary discomfort such as burning,stinging,sneezing,or increased nasal
discharge may occur. ·Use of this container by more than one person may spread infection.

OTC - STOP USE SECTION

Stop Use
Stop use and ask a doctor if symptoms persist

OTC - ASK DOCTOR SECTION

Ask Doctor
children 6 to under 12 years.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep Oot Of Reach Of Children
if swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions
Adults&children 12 years &older(with adult supervision ): 2 or 3 sprays in each nostril,not more often than every 10 to 12 hours.
Do not exceed 2 doses in 24 hours.
Ask a doctor: children 6 to under 12 years.
Do not use children under 6 years
Shake well before use. Before using the first time, remove the protective cap &safely clip from the tip and prime metered pump by depressing firmly severaltimes. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depresspump all the way down with a firm even stroke and sniff deeply. Wipe nozzleclean after use.

OTHER SAFETY INFORMATION

Other information
do not exceed 25°C.Retain the box for future reference on full labeling

INACTIVE INGREDIENT SECTION

Inactive ingredients
Borneol,Camphor,glycerin,propylene glycol

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Drug facts
Drug FactsDrug Facts

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
85248-006DERMFREE ORIGINAL NASAL (NAPHAZOLINE HCL 0.05% ORIGINAL NASAL) SPRAY [JIANGXI YUDEXI PHARMACEUTICAL CO., LTD]1Unmatched20250504_3432c4a6-3e48-db91-e063-6394a90a28ee.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85248-00685248-006-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
51ead28a-8e79-69c1-e063-6294a90ad1a33432c4a6-3e48-db91-e063-6394a90a28ee2026-05-16WarningsExact identifier
spl set id: 3432c4a6-3e48-db91-e063-6394a90a28ee

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.